These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 15314941

  • 1. [The value of VALUE--a hypertension study which compared valsartan with amlodipine. New data support early, optimal blood pressure control for high-risk patients].
    Nilsson PM.
    Lakartidningen; 2004 Jul 22; 101(30-31):2426-7. PubMed ID: 15314941
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Exforge HCT.
    Med Lett Drugs Ther; 2009 Jun 15; 51(1314):47. PubMed ID: 19528888
    [No Abstract] [Full Text] [Related]

  • 4. Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: a comparative study of the efficacy and safety against amlodipine.
    Corea L, Cardoni O, Fogari R, Innocenti P, Porcellati C, Provvidenza M, Meilenbrock S, Sullivan J, Bodin F.
    Clin Pharmacol Ther; 1996 Sep 15; 60(3):341-6. PubMed ID: 8841157
    [Abstract] [Full Text] [Related]

  • 5. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension.
    Philipp T, Smith TR, Glazer R, Wernsing M, Yen J, Jin J, Schneider H, Pospiech R.
    Clin Ther; 2007 Apr 15; 29(4):563-80. PubMed ID: 17617280
    [Abstract] [Full Text] [Related]

  • 6. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial.
    Julius S, Kjeldsen SE, Weber M, Brunner HR, Ekman S, Hansson L, Hua T, Laragh J, McInnes GT, Mitchell L, Plat F, Schork A, Smith B, Zanchetti A, VALUE trial group.
    Lancet; 2004 Jun 19; 363(9426):2022-31. PubMed ID: 15207952
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM, Malacco E, Khder Y, Kandra A, Bönner G, Heintz D.
    Clin Ther; 2005 May 19; 27(5):578-87. PubMed ID: 15978306
    [Abstract] [Full Text] [Related]

  • 8. [Preventing end-organ damage in hypertension. What is the significance of the VALUE Study for general practice?].
    Zidek W.
    MMW Fortschr Med; 2004 Jul 08; 146(27-28):41. PubMed ID: 15526662
    [No Abstract] [Full Text] [Related]

  • 9. Effects of the angiotensin-1 receptor blocker valsartan compared with amlodipine on renal hemodynamics.
    Epstein M, Hollenberg NK.
    Am J Hypertens; 2004 Jul 08; 17(7):638-9; author reply 639-40. PubMed ID: 15233985
    [No Abstract] [Full Text] [Related]

  • 10. Single-pill combination of amlodipine and valsartan in the management of hypertension.
    Flack JM, Hilkert R.
    Expert Opin Pharmacother; 2009 Aug 08; 10(12):1979-94. PubMed ID: 19606937
    [Abstract] [Full Text] [Related]

  • 11. Valsartan treatment of hypertension--does VALUE add value?
    Lindholm LH.
    Lancet; 2004 Jun 19; 363(9426):2010-1. PubMed ID: 15207946
    [No Abstract] [Full Text] [Related]

  • 12. Antihypertensive therapy with CCB/ARB combination in older individuals: focus on amlodipine/valsartan combination.
    Kostis JB.
    Am J Ther; 2010 Jun 19; 17(2):188-96. PubMed ID: 19433970
    [Abstract] [Full Text] [Related]

  • 13. Role of combination therapy in the treatment of hypertension: focus on valsartan plus amlodipine.
    Ferri C, Croce G, Desideri G.
    Adv Ther; 2008 Apr 19; 25(4):300-20. PubMed ID: 18449492
    [Abstract] [Full Text] [Related]

  • 14. Randomized study to compare valsartan +/- HCTZ versus amlodipine +/- HCTZ strategies to maximize blood pressure control.
    Zappe D, Papst CC, Ferber P, PROMPT Investigators.
    Vasc Health Risk Manag; 2009 Apr 19; 5():883-92. PubMed ID: 19898644
    [Abstract] [Full Text] [Related]

  • 15. The VALUE trial: a commentary.
    Sever P.
    J Renin Angiotensin Aldosterone Syst; 2004 Sep 19; 5(3):99-101. PubMed ID: 15526243
    [Abstract] [Full Text] [Related]

  • 16. VALUE: analysis of results.
    Fretheim A.
    Lancet; 2004 Sep 19; 364(9438):934-5; author reply 935. PubMed ID: 15364181
    [No Abstract] [Full Text] [Related]

  • 17. Outcomes in subgroups of hypertensive patients treated with regimens based on valsartan and amlodipine: An analysis of findings from the VALUE trial.
    Zanchetti A, Julius S, Kjeldsen S, McInnes GT, Hua T, Weber M, Laragh JH, Plat F, Battegay E, Calvo-Vargas C, Cieśliński A, Degaute JP, Holwerda NJ, Kobalava J, Pedersen OL, Rudyatmoko FP, Siamopoulos KC, Störset O.
    J Hypertens; 2006 Nov 19; 24(11):2163-8. PubMed ID: 17053536
    [Abstract] [Full Text] [Related]

  • 18. Combination of amlodipine 10 mg and valsartan 160 mg lowers blood pressure in patients with hypertension not controlled by an ACE inhibitor/CCB combination.
    Trenkwalder P, Schaetzl R, Borbas E, Handrock R, Klebs S.
    Blood Press Suppl; 2008 Dec 19; 2():13-21. PubMed ID: 19205092
    [Abstract] [Full Text] [Related]

  • 19. Effective and safe reduction of blood pressure with the combination of amlodipine 5 mg and valsartan 160 mg in hypertensive patients not controlled by calcium channel blocker monotherapy.
    Brachmann J, Ansari A, Mahla G, Handrock R, Klebs S.
    Adv Ther; 2008 May 19; 25(5):399-411. PubMed ID: 18465097
    [Abstract] [Full Text] [Related]

  • 20. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
    Poldermans D, Glazes R, Kargiannis S, Wernsing M, Kaczor J, Chiang YT, Yen J, Gamboa R, Fomina I.
    Clin Ther; 2007 Feb 19; 29(2):279-89. PubMed ID: 17472820
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.